PROPHYLAXIS OF CMV INFECTION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH NILOTINIB : A PHASE II TRIAL

被引：0
|
作者：
Lin, C. T. [1 ,2 ]
Wu, S. J. [1 ]
Li, C. C. [1 ,2 ]
Ko, B. S. [1 ]
Yao, M. [1 ]
Lin, W. P. [1 ]
Tang, J. L. [1 ,2 ]
Tien, H. F. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Tai Cheng Stem Cell Therapy Ctr, Taipei 10764, Taiwan
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1107
引用
收藏
页码：423 / 423
页数：1
相关论文
共 50 条
  • [21] CMV-prophylaxis after T-cell depleted allogeneic stem cell transplantation:: a comparison of 4 regimens
    Von Harsdorf, S
    Bommer, M
    Zenz, T
    Ringhoffer, M
    Schlenk, R
    Schmid, T
    Hampl, W
    Stilgenbauer, S
    Döhner, H
    Mertens, T
    Bunjes, D
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S207 - S207
  • [22] CMV resistance in patients after allogeneic haematopoietic stem cell transplantation
    Hubacek, P.
    Kouba, M.
    Boutolleau, D.
    Pliskova, L.
    Vejrazkova, E.
    Keslova, P.
    Sedlacek, P.
    Cetkovsky, P.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2015, 70 : S125 - S126
  • [23] CMV resistance in patients after allogeneic haematopoietic stem cell transplantation
    Hubacek, P.
    Kouba, M.
    Boutolleau, D.
    Pliskova, L.
    Vejrazkova, E.
    Keslova, P.
    Sedlacek, P.
    Cetkovsky, P.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S78 - S78
  • [24] CMV genotypes in patiens after allogeneic haematopoietic stem cell transplantation
    Hubacek, P.
    Javornicka, T.
    Sumova, J.
    Keslova, P.
    Kouba, M.
    Zajac, M.
    Markova-Stastna, M.
    Sedlacek, P.
    Cetkovsk, P.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S410 - S411
  • [25] Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation
    J A Pérez-Simón
    I García-Escobar
    J Martinez
    L Vazquez
    D Caballero
    C Cañizo
    M V Mateos
    J F San Miguel
    [J]. Bone Marrow Transplantation, 2004, 33 : 183 - 187
  • [26] Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation
    Pérez-Simón, JA
    García-Escobar, I
    Martinez, J
    Vazquez, L
    Caballero, D
    Cañizo, C
    Mateos, MV
    San Miguel, JF
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 (02) : 183 - 187
  • [27] Therapy and prophylaxis of CMV infection in allogeneic stem cells transplant
    Musso, M
    Bondi, F
    Crescimanno, A
    Porretto, F
    Polizzi, V
    Scalone, R
    Mariani, G
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S66 - S66
  • [28] CMV infection in seropositive patients with haematologic malignancies after allogeneic peripheral blood stem cell transplantation
    Tan, T.-D.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S369 - S369
  • [29] Increased risk of complicated CMV infection after the use of mycophenolate mofetil in allogeneic stem cell transplantation
    Hambach, L
    Stadler, M
    Franzke, A
    Biersack, H
    Dammann, E
    Ganser, A
    Hertenstein, B
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S153 - S154
  • [30] CMV infection following nonmyeloablative allogeneic stem cell transplantation using Campath
    Bainton, RD
    Byrne, JL
    Davy, BJ
    Russell, NH
    [J]. BLOOD, 2002, 100 (10) : 3843 - 3844
12345